SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias

CompletedOBSERVATIONAL
Enrollment

6,000

Participants

Timeline

Start Date

February 10, 2004

Primary Completion Date

December 31, 2020

Study Completion Date

December 30, 2020

Conditions
Cerebellar AtaxiasSpastic Paraplegias
Trial Locations (27)

407

Ullevål University Hospital, Oslo

1070

Université Libre de Bruxelles - Hôpital Erasme, Brussels

2200

The Panum Institute, Copenhagen

11000

Clinical Centre of Serbia, Belgrade

11461

King Khalid University Hospital, Riyadh

13000

Hôpital de la Timone, Marseille

16000

CHU Mustapha, Algiers

30000

Hôpital Carémeau, Nîmes

31000

Hôpital Purpan, Toulouse

33000

Hôpital Pellegrin, Bordeaux

38000

CHU, Grenoble

49000

CHU d'Angers, Angers

63000

Hôpitaux de Clermont-Ferrand, Clermont-Ferrand

75012

Hôpital Armand Trousseau, Paris

75013

Pitié-Salpêtrière Hospital, Paris

76000

Hôpital Charles Nicolle, Rouen

80131

Dipartimento Di Scienze Neurologiche, Napoli

91120

Hadassah-Hebrew University Hospital, Jerusalem

00165

Molecular Medicine and Department of Neurosciences, Roma

1107 2180

Université Saint-Joseph, Beirut

Unknown

CHU de Rabat, Rabat

Hôpital Habib Bourguiba, Sfax

6500 HB

Radboud University Nijmegen Medical Centre, Nijmegen

4150-180

University of Porto, Porto

4520-211

Hospital San Sebastião, Santa Maria da Feira

NW3 2PF

Royal Free and University College Medical School, London

WC1N 3BG

The National Hospital, London

All Listed Sponsors
collaborator

Institut des Maladies Rares

UNKNOWN

collaborator

National Research Agency, France

OTHER

collaborator

Paris Brain Institute (ICM)

OTHER

lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT00140829 - SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias | Biotech Hunter | Biotech Hunter